Enabling Research Infrastructure

Connecting biospecimens, data and discovery to better care

The Australian Arthritis and Autoimmune Biobank Collaborative (A3BC) provides national research infrastructure that integrates biospecimens, clinical data, patient‑reported outcomes and health data linkage within a single, governance‑led platform.
By bringing these elements together, A3BC enables research that moves efficiently from discovery to clinical insight, supporting better diagnosis, treatment selection, prevention and long‑term outcomes for people with arthritis and autoimmune disease.

Why this infrastructure matters

Health data are often fragmented across clinical systems, research studies and jurisdictions. This fragmentation limits the ability of researchers and clinicians to:

  • Study disease across the full life course
  • Understand treatment response in real‑world settings
  • Translate research findings into practice and policy

A3BC was established to address these challenges by creating an integrated, longitudinal registry and biobank, embedded within Australia’s health and research ecosystem.

What A3BC enables

A3BC provides:

Integrated registry and biobank infrastructure

  • Longitudinal clinical data, patient‑reported outcomes and biological samples
  • Consistent national standards for collection, processing and governance

Ethics‑approved data linkage

  • Secure linkage to Commonwealth, state and hospital datasets
  • Life‑course follow‑up to support real‑world and outcomes‑based research

Research‑ready datasets

  • Designed for multi‑omic, epidemiological, health economics and implementation research
  • Suitable for observational studies, sub‑studies and partnered clinical trials

Translation‑focused design

  • Infrastructure that supports living guidelines, precision medicine and policy‑relevant evidence
  • Active use in national trials and Centre of Research Excellence

Building capability and collaboration

The A3BC infrastructure supports:

  • Collaboration between clinicians, researchers, consumers and policy partners
  • Training of emerging researchers in registry‑ and biobank‑enabled science
  • Integration with national initiatives, including ARAD, AJAR and the NHMRC‑funded CRE for Better Outcomes in Inflammatory Arthritis

Rather than operating as a static repository, A3BC functions as a living national platform, evolving with scientific advances, regulatory frameworks and community expectations.

Looking ahead

A3BC continues to strengthen its infrastructure through:

  • Secure digital research environments and analytics capabilities
  • Expansion of life‑course and paediatric–adult transition data
  • Partnerships that accelerate translation into clinical practice

This approach ensures that research enabled by A3BC remains relevant, ethical, and impactful.